These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37241785)

  • 41.
    Chowrasia D; Jafri A; Azad I; Rais J; Sharma N; Khan F; Kumar A; Kumar S; Arshad M
    J Biomol Struct Dyn; 2022 Nov; 40(18):8569-8586. PubMed ID: 33955334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Docking Simulation Studies of Curcumin and Its Derivatives as Cyclin-Dependent Kinase 2 Inhibitors.
    Sumirtanurdin R; Sungkar S; Hisprastin Y; Sidharta KD; Nurhikmah DD
    Turk J Pharm Sci; 2020 Aug; 17(4):417-423. PubMed ID: 32939138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
    Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
    Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring inhibitory potential of Curcumin against various cancer targets by in silico virtual screening.
    Mahajanakatti AB; Murthy G; Sharma N; Skariyachan S
    Interdiscip Sci; 2014 Mar; 6(1):13-24. PubMed ID: 24464700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds.
    Vora J; Patel S; Athar M; Sinha S; Chhabria MT; Jha PC; Shrivastava N
    J Biomol Struct Dyn; 2020 Apr; 38(6):1726-1740. PubMed ID: 31057055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacophore modelling, docking and molecular dynamic simulation studies in the discovery of potential human renin inhibitors.
    Halimi M; Hajipasha A
    J Mol Graph Model; 2022 Nov; 116():108272. PubMed ID: 35932508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
    Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
    J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In silico discovery of potential VEGFR-2 inhibitors from natural derivatives for anti-angiogenesis therapy.
    Li J; Zhou N; Luo K; Zhang W; Li X; Wu C; Bao J
    Int J Mol Sci; 2014 Sep; 15(9):15994-6011. PubMed ID: 25216334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In silico discovery of food-derived phytochemicals against asialoglycoprotein receptor 1 for treatment of hypercholesterolemia: Pharmacophore modeling, molecular docking and molecular dynamics simulation approach.
    Gao S; Wang L; Bai F; Xu S
    J Mol Graph Model; 2023 Dec; 125():108614. PubMed ID: 37651861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches.
    Babu S; Nagarajan SK; Sathish S; Negi VS; Sohn H; Madhavan T
    Front Pharmacol; 2022; 13():837369. PubMed ID: 35529449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proposing novel TNF╬▒ direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
    Zaka M; Abbasi BH; Durdagi S
    J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
    Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of Small Molecules that Target Vascular Endothelial Growth Factor Receptor-2 Signalling Pathway Employing Molecular Modelling Studies.
    Rampogu S; Baek A; Park C; Parate S; Parameswaran S; Park Y; Shaik B; Kim JH; Park SJ; Lee KW
    Cells; 2019 Mar; 8(3):. PubMed ID: 30901950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacophore-based virtual screening and
    Roney M; Huq AKMM; Issahaku AR; Soliman MES; Hossain MS; Mustafa AH; Islam MA; Dubey A; Tufail A; Mohd Aluwi MFF; Tajuddin SN
    J Biomol Struct Dyn; 2023; 41(21):12186-12203. PubMed ID: 36645141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches.
    Pundir H; Joshi T; Pant M; Bhat S; Pandey J; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022; 40(24):13366-13377. PubMed ID: 34637693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors.
    Singh R; Pokle AV; Ghosh P; Ganeshpurkar A; Swetha R; Singh SK; Kumar A
    J Biomol Struct Dyn; 2023; 41(13):6089-6103. PubMed ID: 35862656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of novel leads as potent inhibitors of HDAC3 using ligand-based pharmacophore modeling and MD simulation.
    Kumbhar N; Nimal S; Barale S; Kamble S; Bavi R; Sonawane K; Gacche R
    Sci Rep; 2022 Feb; 12(1):1712. PubMed ID: 35110603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.